These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 17414228

  • 1. Add-on amlodipine improves arterial function and structure in hypertensive patients treated with an angiotensin receptor blocker.
    Ichihara A, Kaneshiro Y, Sakoda M, Takemitsu T, Itoh H.
    J Cardiovasc Pharmacol; 2007 Mar; 49(3):161-6. PubMed ID: 17414228
    [Abstract] [Full Text] [Related]

  • 2. Add-on benefits of amlodipine and thiazide in nondiabetic chronic kidney disease stage 1/2 patients treated with valsartan.
    Kaneshiro Y, Ichihara A, Sakoda M, Kurauchi-Mito A, Kinouchi K, Itoh H.
    Kidney Blood Press Res; 2009 Mar; 32(1):51-8. PubMed ID: 19258723
    [Abstract] [Full Text] [Related]

  • 3. Effects of amlodipine and valsartan on vascular damage and ambulatory blood pressure in untreated hypertensive patients.
    Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M.
    J Hum Hypertens; 2006 Oct; 20(10):787-94. PubMed ID: 16810279
    [Abstract] [Full Text] [Related]

  • 4. Comparison of effects of amlodipine and angiotensin receptor blockers on the intima-media thickness of carotid arterial wall (AAA study: amlodipine vs. ARB in atherosclerosis study).
    Ikeda H, Minamikawa J, Nakamura Y, Honjo S, Hamamoto Y, Wada Y, Nabe K, Koshiyama H.
    Diabetes Res Clin Pract; 2009 Jan; 83(1):50-3. PubMed ID: 19070383
    [Abstract] [Full Text] [Related]

  • 5. Benefits of candesartan on arterial and renal damage of non-diabetic hypertensive patients treated with calcium channel blockers.
    Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Itoh H.
    Am J Nephrol; 2006 Jan; 26(5):462-8. PubMed ID: 17063001
    [Abstract] [Full Text] [Related]

  • 6. Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
    Maeda A, Tamura K, Kanaoka T, Ohsawa M, Haku S, Azushima K, Dejima T, Wakui H, Yanagi M, Okano Y, Fujikawa T, Toya Y, Mizushima S, Tochikubo O, Umemura S.
    Clin Exp Hypertens; 2012 Jan; 34(4):249-57. PubMed ID: 22571446
    [Abstract] [Full Text] [Related]

  • 7. Renoprotective effect of calcium channel blockers in combination with an angiotensin receptor blocker in elderly patients with hypertension. A randomized crossover trial between benidipine and amlodipine.
    Miyagawa K, Dohi Y, Nakazawa A, Sugiura T, Yamashita S, Sato K, Kimura G.
    Clin Exp Hypertens; 2010 Jan; 32(1):1-7. PubMed ID: 20144066
    [Abstract] [Full Text] [Related]

  • 8. Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA study.
    Martinez-Martin FJ, Saiz-Satjes M.
    Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1347-55. PubMed ID: 19018688
    [Abstract] [Full Text] [Related]

  • 9. Control of home blood pressure with an amlodipine- or losartan-based regimen and progression of carotid artery intima-media thickness in hypertensive patients: the HOSP substudy.
    Ohta Y, Kawano Y, Iwashima Y, Hayashi S, Yoshihara F, Matayoshi T, Takiuchi S, Kamide K, Nakamura S, Horio T.
    Clin Exp Hypertens; 2013 Nov; 35(4):279-84. PubMed ID: 23530977
    [Abstract] [Full Text] [Related]

  • 10. Candesartan decreases carotid intima-media thickness by enhancing nitric oxide and decreasing oxidative stress in patients with hypertension.
    Ono H, Minatoguchi S, Watanabe K, Yamada Y, Mizukusa T, Kawasaki H, Takahashi H, Uno T, Tsukamoto T, Hiei K, Fujiwara H.
    Hypertens Res; 2008 Feb; 31(2):271-9. PubMed ID: 18360047
    [Abstract] [Full Text] [Related]

  • 11. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S, Maki K, Aota Y, Sakuma T, Iwasaka T.
    Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
    [Abstract] [Full Text] [Related]

  • 12. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H, Kim-Mitsuyama S, Jinnouchi T, Matsui K, Arakawa K.
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [Abstract] [Full Text] [Related]

  • 13. Effects of angiotensin II type 1 receptor blocker on blood pressure variability and cardiovascular remodeling in hypertensive patients on chronic peritoneal dialysis.
    Shigenaga A, Tamura K, Dejima T, Ozawa M, Wakui H, Masuda S, Azuma K, Tsurumi-Ikeya Y, Mitsuhashi H, Okano Y, Kokuho T, Sugano T, Ishigami T, Toya Y, Uchino K, Tokita Y, Umemura S.
    Nephron Clin Pract; 2009 Jul; 112(1):c31-40. PubMed ID: 19342867
    [Abstract] [Full Text] [Related]

  • 14. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 15. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 16. Does blockade of the renin angiotensin system affect sympathetic and blood pressure responses to amlodipine in young hypertensive patients?
    Ruzicka M, Coletta E, Leenen FH.
    Am J Hypertens; 2007 Nov; 20(11):1202-8. PubMed ID: 17954368
    [Abstract] [Full Text] [Related]

  • 17. Is renoprotection by angiotensin receptor blocker dependent on blood pressure?: the Saitama Medical School, Albuminuria Reduction in Diabetics with Valsartan (STAR) study.
    Katayama S, Yagi S, Yamamoto H, Yamaguchi M, Izumida T, Noguchi Y, Inaba M, Inukai K.
    Hypertens Res; 2007 Jun; 30(6):529-33. PubMed ID: 17664856
    [Abstract] [Full Text] [Related]

  • 18. Smoking and antihypertensive medication: interaction between blood pressure reduction and arterial stiffness.
    Matsui Y, Kario K, Ishikawa J, Hoshide S, Eguchi K, Shimada K.
    Hypertens Res; 2005 Aug; 28(8):631-8. PubMed ID: 16392766
    [Abstract] [Full Text] [Related]

  • 19. Higher small arterial elasticity in hypertensive patients treated with angiotensin II receptor blockers.
    Takeuchi K, Ideishi M, Tashiro T, Morishige N, Yamada T, Saku K, Urata H.
    Hypertens Res; 2005 Aug; 28(8):639-44. PubMed ID: 16392767
    [Abstract] [Full Text] [Related]

  • 20. Renoprotective effect and cost-effectiveness of using benidipine, a calcium channel blocker, to lower the dose of angiotensin receptor blocker in hypertensive patients with albuminuria.
    Saito F, Fujita H, Takahashi A, Ichiyama I, Harasawa S, Oiwa K, Takahashi N, Otsuka Y, Uchiyama T, Kanmatsuse K, Kushiro T.
    Hypertens Res; 2007 Jan; 30(1):39-47. PubMed ID: 17460370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.